ALKERMES | ALKS - ДОЛГ





ДОЛГ Изменить Дата
AbbVie USD 70.82B 2.04B 2026-06
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
ALKERMES USD 1.58B 1.51B 2026-03
Amgen USD 57.32B 2.72B 2026-03
Biogen USD 7.69B 398.3M 2026-09
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 54.91B 11.54B 2026-06
Gilead Sciences USD 26.25B 4.07B 2026-06
Heron Therapeutics USD 149.65M 157K 2024-09
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
J&J USD 49.04B 5.95B 2026-06
Malin Corporation EUR 100K 0 2023-12
Merck USD 53.91B 4.79B 2026-06
Minerva Neurosciences USD 0 0 2024-09
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
Otsuka Holdings JPY 194.2B 33.77B 2026-06
Ovoca Bio EUR 0 0 2021-06
Pfizer USD 63.19B 536M 2026-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06